Search - tctmd.com

Displaying 121 - 140 of 1718

Sort: Relevancy | Date

News Conference News AHA 2024

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

Todd Neale

November 18, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News VIVA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

L.A. McKeown

November 14, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Caitlin E. Cox

November 04, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

Presentation TCT 2024

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

Presenter: han zhang

October 29, 2024

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

Presenter: Hao-Yu Wang

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Daily News

Level of Consciousness After Cardiac Arrest Correlates With Post-PCI Outcomes

Yael L. Maxwell

October 25, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

Advertisement

OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now?

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Vascular Closure via Suture/Plug Combo Reduces Complications: ACCESS-TAVI

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

TCT 218: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention in Patients With and Without Multivessel Disease: A Pre-Specified Substudy From the FAVOR III China Trial

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

TCT 18: The Impact of Coronary Physiology on the Initial Treatment Strategy for Percutaneous Coronary Intervention: Insights From FAVOR III China Trial

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Level of Consciousness After Cardiac Arrest Correlates With Post-PCI Outcomes

Will Semaglutide Change Cardiac Surgery? It Already Has

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content